Elaine Lissner is the founder and trustee of San Francisco-based Parsemus Foundation, one of the few foundations conducting research on contraceptive development. The foundation both supports researchers working on human and animal contraception, among other projects, and directly conducts program-related research. She has led Parsemus Foundation to debunk medical myths, develop new low-cost healthcare options for humans and animals, and publicize the results to physicians, veterinarians and the public. She also serves as managing director of the social venture Revolution Contraceptives, which is developing Vasalgel male contraceptive. A Stanford graduate and longtime advocate of male contraceptive development, Ms. Lissner was founder and director of the Male Contraception Information Project in the early 1990’s and director from 2001 to 2015. Her publications include “Frontiers in Nonhormonal Male Contraception: A Call for Research”, and the foundation’s work has been featured in Scientific American, BBC News, the New York Times, and The Wall Street Journal. Ms. Lissner serves on the scientific Advisory Board of the Alliance for Contraception in Cats and Dogs.